#EBMT24 Dr Hasmukh Hasmukh Jain presented “EBMT contest session” the story of CART cell therapy program in India- with a focus on scale and access & WON the contest. 🥂 Dr Hasmukh & team Tata Memorial Hospital ImmunoACT Laurus Labs IIT Bombay ICMR DBT-BIRAC The EBMT Anna Sureda

We are thrilled and honoured by your esteemed presence Hon President Madam President of India and dedicate CAR-T cell therapy to nation. Hopefully this will help million of patients. Hasmukh Jain Gaurav Narula MD NIH Nirali Shah Laurus Labs Tata Memorial Hospital IIT Bombay

Well researched!🙏 Devina Sengupta.
CAR-T therapy- indigenously developed #MakeInIndia gene therapy puts India on Global map. Exceptional collaboration IIT Bombay Tata Memorial Hospital Hasmukh Jain Jayashree Thorat Gaurav Narula MD ImmunoACT & NCI Center for Cancer Research Alka Dwivedi Atharva Karulkar

A professor at IIT Bombay & docs in Tata Memorial Hospital developed a #cancer therapy over 7 yrs. Large pharma firms scoffed. Today, 98 patients have received the drug,50% show +response. Global scientists are shocked. How did they manage ? What’s their story? I find out Mint

Atharva from ⁦ImmunoACT⁩ explaining to ⁦Bill Gates⁩ about how we are ensuring “access” of CAR-T cell therapy for cancer in India. Until recently, CAR-T was not available in India due to high cost (~400,000 USD per patient). Our efforts reduced the cost by >90%.

Excellent study! And I completely agree that POC in CART has fewer benefits then associated risks. In country like India, centralized (regional decentralisation) manufacturing with appropriate controls is key for manufacturing high quality CAR-T cells for our patients.

Discussion about CAR-T in Gujrati news!

Our wonderful collaborator and an excellent physician Gaurav Narula MD talking about the CART cell therapy development in India!

Excellent article published by NIH/NCI. Can't thank enough National Cancer Institute for their support.

Please checkout our excellent article on NCI’s role in developing first indigenous NexCAR19. NCI CCR Pediatric Oncology Branch Nirali Shah Rahul Purwar Gaurav Narula MD ImmunoACT

cancer.gov/news-events/ca…

Discussion with ⁦Naveen Pemmaraju, MD⁩ on Indian CART and future collab at Amrita Faridabad #ILA24 ⁦Prashant Mehta⁩

Today we met Hon’ble Madam President to explain her about gene therapy (CAR-T cell) developed at IIT Bombay & Tata Memorial Hospital & ImmunoACT Gaurav Narula MD Hasmukh Jain Laurus Labs

Starting the day at Sandiego with Indian CAR T cell therapy pioneers #nexcar19 #ASH23 # ASH2023 ⁦Rahul Purwar⁩ ⁦Hasmukh Jain⁩ ⁦Atharva Karulkar⁩ ⁦Ramaiah Memorial Hospital⁩ ⁦Ramaiah Medical College⁩ ⁦Ramaiah University of Applied Sciences⁩ ⁦Tata Memorial Hospital⁩ ⁦⁦ImmunoACT⁩

Spoke about first #MakeinIndia #CARTcell therapy and explained it to Prof Balram Bhargava ICMR and Prof Vinod Paul NITI Aayog. they extended their full support to scale up and making it accessable across the country Tata Memorial Hospital IIT Bombay SINE IITB DBT-BIRAC

Embracing opportunities & Charting the path forward in the Indian Healthcare & Pharma Industry

PwC & CNBC-TV18 present CEO DIALOGUES on 4th November (Saturday) @ 5:30pm only on CNBC-TV18

PwC India Shereen Bhan Sanjeev Krishnan Ameera Shah Metropolis Healthcare Ltd G Khanna P. D. Hinduja Hospital

Ritika Chopra & I spoke with Prof Rahul Purwar, ImmunoACT who explained #NexCAR19 's superior effectiveness with lower drug-related side effects. Partnered with hospitals in Mumbai, Pune, & Delhi for wider availability for non-responsive cancer patients.
google.com/amp/s/indianex…

Highly talented ⁦Bhavuk Dhamija⁩ successfully defended his PhD thesis today! Bhavuk has been in the lab, first as a Master student & then as a PhD student! we are super proud of his achievements and wish him the very best in his future endeavours.

It was indeed very engaging & important discussion led by brilliant Shereen Bhan ! And tiramisu- pick me up- was fun.

Thanks a lot Honourable Shri Thorat sir for the best wishes. While a team was involved, but for this one, credit goes to brilliant Dr Hasmukh Jain- who worked extremely hard to ensure-trial is successful. History will remember Dr Hasmukh and we all owe this one to you!

Thanks a lot Dr Pramesh sir! This is an incredible win for our patients and an excellent example of TMH and IITB research. Wish to continue our research collaborations and develop good quality medicine to help our patients.